RE:RE:RE:RE:RE:RE:RE:RE:Big NewsThanks lscfa, segmentation makes absolute sense. Glad to hear it's on their radar for 2021 although after hearing jfeom other sector leaders ust how challenging this certification is to procure, I'll be amazed (and pleased) if Valens gets it on the timetable they're thinking. There's a reason only a handful of companies have obtained it. Thus the extreme pricing differentials within the medical white label business